Publications found:
139
Sort by:
Global Semaglutide Preparations Market Growth 2026-2032
US$ 3,660.00
The global Semaglutide Preparations market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Semaglutide preparations r...
January 2026
78 pages
Non-Injectable Insulin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Pills, Sprays, and Others), By Distribution Channel (Hospital Pharmacies, and Online Pharmacies, Drug Stores), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Non-Injectable Insulin Market is projected to expand from USD 3.69 Billion in 2025 to USD 6.46 Billion by 2031, registering a CAGR of 9.78%. This market sector focuses on alternative admini...
January 2026
185 pages
Next Generation Diabetes Therapy and Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Inhalable Insulin, Oral Insulin, Insulin Patches, CGM Systems, Artificial Pancreas), By Indication (Type 1 diabetes, Type 2 diabetes), By End user (Diagnostic/Clinics, Intensive Care Units (ICUs), Home Healthcare), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Next Generation Diabetes Therapy and Drug Delivery Market is projected to expand from USD 23.86 Billion in 2025 to USD 36.31 Billion by 2031, reflecting a compound annual growth rate of 7.2...
January 2026
182 pages
Short-Acting Insulin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drugs (Apidra, Novolog, Humalog, Novolin, Others), By Application (Type 1 Diabetes, Type 2 Diabetes), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Short-Acting Insulin Market is projected to expand from USD 8.16 billion in 2025 to USD 10.49 billion by 2031, achieving a compound annual growth rate of 4.27%. This therapeutic category fu...
January 2026
185 pages
Antidiabetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Insulin, GLP-1 Receptor Agonists, DPP- 4 Inhibitors, SGLT2 Inhibitors, Others), By Type (Type 1, Type 2), By Route of Administration (Oral, Subcutaneous, Intravenous), By Distribution Channel (Online pharmacies, Hospital Pharmacies, Retail pharmacies),By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Antidiabetics Market is projected to expand significantly, growing from USD 90.99 Billion in 2025 to USD 167.18 Billion by 2031, reflecting a CAGR of 10.67%. These pharmaceutical formulatio...
January 2026
181 pages
Metformin HCL Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By End-Use Application (Anti-diabetic Agent, and Others), By Sales Channel (Direct Sale, Indirect Sale), By Form (Tablets, Extended-Release Tablets, Oral Solutions, Injectable Solutions), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Metformin HCL Market is projected to expand from a volume of 90.23 Thousand Tonnes in 2025 to 124.84 Thousand Tonnes by 2031, reflecting a CAGR of 5.56%. As a biguanide antihyperglycemic ag...
January 2026
180 pages
Diabetes Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors, Others), By Diabetes Type (Type 1, Type 2, Gestational), By Route of Administration (Oral, Subcutaneous, Intravenous), By Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Diabetes Drugs Market is projected to expand from a valuation of USD 91.23 Billion in 2025 to USD 139.93 Billion by 2031, reflecting a CAGR of 7.39%. These pharmaceutical agents, including...
January 2026
180 pages
Human Insulin Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Type I Diabetes, Type II Diabetes), By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N), By Route of Administration (Subcutaneous, Transdermal, Nasal, Intravenous, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid acting, Short-acting, Intermediate acting, Long acting, Pre-Mixed, Inhaled, Ultra-long Acting), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injections), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Human Insulin Market is projected to expand from USD 24.81 Billion in 2025 to USD 38.31 Billion by 2031, reflecting a compound annual growth rate of 7.51%. This sector covers the commercial...
January 2026
180 pages
Insulin Pills Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, Segmented By Form (Tablet v/s Capsule), By Type of Insulin (Long-Acting Insulin, Short-Acting Insulin, Rapid-Acting Insulin), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Insulin Pills Market is projected to grow from USD 0.04 Billion in 2025 to USD 0.15 Billion by 2031, expanding at a CAGR of 24.64%. This market focuses on the development of oral insulin fo...
January 2026
180 pages
The 2027-2032 World Outlook for Diabetes Drugs
US$ 1,195.00
This study covers the world outlook for diabetes drugs across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for diabetes drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country ...
January 2026
287 pages
The 2027-2032 World Outlook for Human Insulin
US$ 1,195.00
This study covers the world outlook for human insulin across more than 190 countries. For each year ... . This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product ...
January 2026
287 pages
The 2027-2032 World Outlook for Type 2 Diabetes Mellitus Treatments
US$ 1,195.00
This study covers the world outlook for type 2 diabetes mellitus treatments across more than 190 countries. For each year reported, ... demand, or the P.I.E., for type 2 diabetes mellitus treatments. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...
January 2026
290 pages
Global Liraglutide Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... , from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Liraglutide in global market, especially in North America, Europe ... growth rate by type, application, from 2014 to 2019. Chapter 12, Liraglutide market forecast, by regions, type and application, with ...
January 2026
104 pages
Global Insulin Glargine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... are 15 Chapters to deeply display the global Insulin Glargine market. Chapter 1, to describe Insulin Glargine Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the ...
January 2026
72 pages
Global Acarbose Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Acarbose in global market, especially in North America, Europe ... growth rate by type, application, from 2014 to 2019. Chapter 12, Acarbose market forecast, by regions, type and application, with ...
January 2026
95 pages
The 2027-2032 World Outlook for Diabetes Therapeutics
US$ 1,195.00
This study covers the world outlook for diabetes therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
288 pages
The 2027-2032 World Outlook for Human Insulin Drugs
US$ 1,195.00
This study covers the world outlook for human insulin drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
288 pages
Global Acarbose Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global Acarbose market size is expected to reach $ 186 million by 2032, rising at a market growth of 2.7% CAGR during the forecast period (2026-2032). Acarbose is a kind of API that is white powde...
January 2026
108 pages
Diabetic Ketoacidosis Market - 2022-2030
US$ 2,999.00
The Diabetic Ketoacidosis Market was valued at US$ 1.5 billion in 2022 and is anticipated to reach US$ 2.3 billion by 2030, at a CAGR of 0.058 from 2026 to 2032. The report delivers in-depth insights...
December 2025
223 pages
Diabetic Neuropathic Pain Market - 2022-2030
US$ 2,999.00
The Diabetic Neuropathic Pain Market was valued at US$ 1.8 billion in 2022 and is anticipated to reach US$ 2.8 billion by 2030, at a CAGR of 0.061 from 2026 to 2032. The report delivers in-depth insig...
December 2025
200 pages
Global GLP-1 Analogues Market
US$ 2,950.00
: This report presents detailed information on glucagon-like peptide-1 (GLP-1) analogues. It examines market trends for GLP-1 analogues using data from 2024, estimates for 2025, and projected compou...
December 2025
85 pages
Basal Insulin (Long-Acting Insulin) Market - 2022
US$ 2,999.00
The Basal Insulin (Long-Acting Insulin) Market was valued at USD 234.8 million in 2022 and is anticipated to reach by , at a CAGR of 0.045 from 2026 to 2032. The report delivers in-depth insights into...
November 2025
218 pages
Diabetic Gastroparesis Treatment Market - 2022-2030
US$ 2,999.00
The Diabetic Gastroparesis Treatment Market was valued at US$ 3.1 billion in 2022 and is anticipated to reach US$ 4.2 billion by 2030, at a CAGR of 0.038 from 2026 to 2032. The report delivers in-dept...
November 2025
207 pages
Diabetic Nephropathy Market - 2023-2031
US$ 2,999.00
The Diabetic Nephropathy Market was valued at US$ 205 million in 2023 and is anticipated to reach US$ 332 million by 2031, at a CAGR of 0.062 from 2026 to 2032. The report delivers in-depth insights i...
November 2025
200 pages
Insulin Glargine Market 2026
US$ 2,999.00
The Insulin Glargine Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gro...
November 2025
223 pages
Oral Anti Diabetes Drugs Market - 2022
US$ 2,999.00
The Oral Anti Diabetes Drugs Market was valued at USD 44.3 billion in 2022 and is anticipated to reach by , at a CAGR of 0.08 from 2026 to 2032. The report delivers in-depth insights into key market d...
November 2025
210 pages
Short-Acting Insulin Market 2026
US$ 2,999.00
The Short-Acting Insulin Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
207 pages
Recombinant Cell Culture Insulin Market Size, Share & Trends Analysis Report By Type (Stand-alone Powder, Liquid Insulin, Combined kits & Cocktails), By End-use (Vaccine Manufacturers, Regenerative Medicine, CMOs & CROs, Academic Research Institutes), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global recombinant cell culture insulin market size was estimated at USD 233.0 million in 2024 and is projected to reach USD 665.3 million by 2033, growing at a CAGR of 12.5% from 2025 to 2033. Th...
November 2025
150 pages
GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, tirzepatide), Type (Patented, Biosimilars), Format (Single dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033
US$ 4,950.00
The GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period. The GLP-1 agonists market has expanded rapidly d...
October 2025
456 pages
Glucagon-Like Peptide 1 Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Trulicity, Ozempic, Victoza, Rybelsus, Other Types), By Route of Administration (Oral, Parenteral, Other Routes), By End-Users
US$ 3,950.00
The Glucagon-Like Peptide 1 Market is valued at USD 18.1 billion in 2025 and is projected to grow at a CAGR of 8.1% to reach USD 36.5 billion by 2034. Glucagon-like Peptide 1 Market Overview The Gluca...
October 2025
160 pages
Insulin Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Basal Or Long-Acting Insulins, Bolus Or Fast-Acting Insulins, Pre-Mixed, And Intermediate And Short Acting Insulins), By Source Type (Insulin Analogs, And Human Insulin), By Drug Classification, By Application, By Distribution Channel
US$ 3,950.00
The Insulin Drugs Market is valued at USD 33.1 billion in 2025 and is projected to grow at a CAGR of 12.8% to reach USD 97.6 billion by 2034.The global insulin drugs market has become a cornerstone of...
October 2025
160 pages
